Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Brain-Training class ease mental illness symptoms?

NCT ID NCT07051746

Symptom relief Sponsor: ZI-YU LIN Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a group therapy program called Metacognitive Training (MCT) in 18 Taiwanese adults with schizophrenia, major depression, or bipolar disorder. Over 4 weeks, participants attended 8 sessions that taught them to spot and reduce thinking biases linked to symptoms like delusions and low mood. The goal was to see if the program could improve symptoms, thinking skills, and daily function. Because the study was small and had no comparison group, the results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Metacognitive Training (MCT) – a group therapy program that teaches people to recognize and reduce thinking biases
What this could lead to
If it works, this could offer a low-cost, drug-free way to help people with mental disorders manage symptoms like delusions, depression, and anxiety.
What could go wrong
This is a very small, single-group study with no comparison group, so results may be due to chance or other factors. It also only includes people from one hospital in Taiwan, so findings may not apply to others.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Oct 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 75 years. * Diagnosed with schizophrenia, major depressive disorder, or bipolar disorder based on DSM-5 criteria by a psychiatrist. * Currently enrolled in a psychiatric day hospital. * Judged by an occupational therapist as capable of understanding written/spoken Mandarin and completing Chinese-language questionnaires. * No changes in psychiatric medication within the past month. Exclusion Criteria: * History of severe hearing or visual impairments. * Severe psychiatric symptoms or attention deficits that would prevent full participation in a 60-minute session, as judged by the therapist. * Presence of inappropriate social behaviors such as aggression, sexual harassment, or antisocial behavior. * Ongoing major life crises or recent traumatic events.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bipolar disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bipolar disorder major depressive disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bipolar disorder Major depressive disorder Schizophrenia

Contacts and locations

Locations

  • National Taiwan University Hospital, Department of Psychiatry, General Psychiatry Day Hospital

    Taipei, Taiwan Province, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.